Lab marker

PSA

Prostate-specific antigen

Men's most-discussed and most-controversial tumour marker, useful but only in the context of informed shared decision-making.

Strong relevance10 cited sourcesNo fasting€20–50 private; coverage varies (screening PSA is usually self-pay in Germany).nutrition

What it measures

A serine protease produced almost exclusively by prostate epithelial cells. Elevated by prostate cancer but also by benign prostatic hyperplasia, prostatitis, recent ejaculation, urinary tract infection, and prostate manipulation (DRE, biopsy, cycling). Reported in ng/mL.

Reference context

2 guideline sources

Single PSA values are noisy; repeat after 4–6 weeks before action, and exclude transient causes (ejaculation, UTI, vigorous exercise). PSA velocity (rate of change) and PSA density (PSA / prostate volume on MRI) refine interpretation. The Stockholm3 test combines PSA with other biomarkers and kallikreins to reduce unnecessary biopsies; ERSPC follow-up has confirmed a prostate-cancer mortality reduction with organised screening, now reported at 23 years (13% relative reduction; one death prevented per 456 men invited), alongside overdiagnosis.

Population context: consult guideline targets below

Mechanism

Why moving this marker matters

Prostate cancer cells leak PSA more freely than normal prostate tissue. Population screening has been shown to reduce prostate-cancer mortality (ERSPC, Göteborg) but at the cost of substantial overdiagnosis and overtreatment of indolent cancers that would never have caused harm. The evidence balance has been the subject of major guideline revisions over the past decade.

Guideline targets

What major guidelines recommend

Common reference (general adult action threshold)

Strong

>3 ng/mL → consider further evaluation (mpMRI, repeat testing). >4 ng/mL has been the historical biopsy threshold but is now considered too aggressive.

Age-specific reference ranges (Oesterling 1993, rough guide)

Moderate

<2.5 ng/mL under 50; <3.5 ng/mL 50–59; <4.5 ng/mL 60–69; <6.5 ng/mL 70+. Not a reason to ignore a rising PSA.

How to measure

The test, where to get it, when to repeat

Method

Standard blood draw. Avoid ejaculation in the 48 hours before testing; avoid testing within 6 weeks of UTI, prostatitis, biopsy, or vigorous cycling.

Where

GP request or private lab. Germany: GKV covers DRE from 45; PSA usually self-pay. UK: not offered as routine screening. US: shared decision-making, typically from age 50–55, earlier with risk factors.

Typical cost

€20–50 private; coverage varies (screening PSA is usually self-pay in Germany).

Fasting

Not required

When to test

  • USPSTF 2018

    55–69male

    Grade C (individual decision) for men 55–69; Grade D (recommend against) for men 70+. Understanding the overdiagnosis trade-off is central to the decision.

  • EAU 2024

    50+male

    Risk-adapted screening from age 50 (or 45 with family history / African ancestry). Multiparametric MRI before biopsy if PSA elevated.

  • ACS 2024

    male

    Shared decision-making from age 50; from 45 with elevated risk (family history, African American men).

Where to test

Independent labs offering this test

Healicus refers you to independent laboratories. You order from the lab; they take the sample, run it, and return your result on their own platform. Healicus never sees your value.

Healicus is not the provider. Your contract for the service is with whoever you choose. Links labelled Sponsored are paid affiliate relationships; unlabelled links are editorial reference only. See our disclosure for the full policy.

Context

Reading the numbers

Single PSA values are noisy; repeat after 4–6 weeks before action, and exclude transient causes (ejaculation, UTI, vigorous exercise). PSA velocity (rate of change) and PSA density (PSA / prostate volume on MRI) refine interpretation. The Stockholm3 test combines PSA with other biomarkers and kallikreins to reduce unnecessary biopsies; ERSPC follow-up has confirmed a prostate-cancer mortality reduction with organised screening, now reported at 23 years (13% relative reduction; one death prevented per 456 men invited), alongside overdiagnosis.

Caveats

PSA screening's benefits and harms balance differently for different men; informed discussion before testing is the standard of care, not optional. A PSA above threshold typically leads to mpMRI before biopsy in modern protocols; this has substantially reduced unnecessary biopsy rates. 5-alpha-reductase inhibitors (finasteride, dutasteride) roughly halve PSA. Tell your doctor if you take them.

Practices

What's been shown to influence this marker

A 2019 systematic review for the US physical activity guidelines found only moderate or limited evidence linking more physical activity with lower mortality after a prostate cancer diagnosis; any effect on PSA values is not established.

In a large US cohort (Health Professionals Follow-up Study), Mediterranean-diet adherence was not associated with advanced or lethal prostate cancer; among men already diagnosed, closer adherence was associated with lower overall mortality. Effects on PSA itself are not established.

A meta-analysis of observational studies (Zhao 2016) reported a dose-related association between alcohol intake and prostate cancer risk; effects on PSA values are not established.

Limit alcohol intakeCautionHabit
Preliminary evidence

Limit alcohol intake

Meta-analysis of 107 cohort studies: drinking 45 g or more of alcohol a day was linked to higher all-cause mortality, while low-volume drinking showed no significant difference.

Read full evidence

Why

A 2023 JAMA Network Open meta-analysis of 107 cohort studies (n=4,838,825) found higher all-cause mortality in people drinking 45 g or more of alcohol per day than in lifetime nondrinkers, with women at higher risk. Low-volume drinking showed no significant mortality difference once biases were corrected, so light drinking is not shown to be protective. The US Preventive Services Task Force advises screening and brief counselling for adults who drink above recommended limits.

How to do it

How

Track intake honestly for one week. If above threshold, set a weekly cap rather than a daily one (avoids the 'I'll catch up' trap). Several alcohol-free days per week is the simplest pattern. Sleep quality typically improves within 1-2 weeks of reduced intake.

Ideal for

Anyone currently drinking heavily or above recommended limits.

Markers this may influence

Caution: Sudden cessation in heavy drinkers can cause withdrawal, taper or seek medical guidance if you've been drinking heavily for years.

Evidence

At a glance

Zhao 2023 JAMA Netw Open meta-analysis of 107 cohort studies (n=4,838,825): drinkers of 45 g or more of alcohol per day had higher all-cause mortality than lifetime nondrinkers (RR 1.19 and 1.35), while low-volume drinking showed no significant difference. The US Preventive Services Task Force (2018) recommends screening adults and offering brief counselling to those drinking above recommended limits.

GRADE certainty: Low — rated by Healicus using the GRADE method

Mediterranean dietary patternHabit
Moderate evidence

Mediterranean dietary pattern

Olive oil, fish, nuts, legumes, plants. Two randomised trials found fewer major cardiovascular events than a low-fat diet.

Read full evidence

Why

The Mediterranean pattern, heavy on plants, olive oil, fish, nuts, legumes; moderate fish and dairy; light on red meat, has randomised-trial evidence for fewer major cardiovascular events than a low-fat diet in adults at high cardiovascular risk. PREDIMED, the largest trial (republished after protocol deviations), showed ~30% fewer major cardiovascular events vs. low-fat control. Trial evidence for cognition is thin.

Slot in your day

With a meal

How to do it

How

Olive oil as the primary fat. Plants at every meal. Fish 2–3× per week. Nuts daily (small handful). Red meat once a week or less. Alcohol is not needed for the pattern; low-volume drinking has not been shown to be protective.

Sticking with it

Stock the kitchen for one week's pattern. Decisions live in the shopping list, not at mealtime.

Markers this may influence

Evidence

At a glance

Estruch 2018 N Engl J Med RCT (n=7,447, adults at high cardiovascular risk, republished after protocol deviations): a Mediterranean diet with olive oil or nuts had fewer major cardiovascular events than a control diet advising less fat (hazard ratios 0.69 and 0.72). Delgado-Lista 2022 Lancet RCT (n=1,002, coronary heart disease) found a similar direction versus a low-fat diet, mainly in men. Trial evidence for cognition is thin.

GRADE certainty: Moderate — rated by Healicus using the GRADE method (RCT evidence; downgraded for protocol deviations/no blinding in the main trials and for indirectness of dietary-pattern comparisons)

Zone 2 cardioHabit
Moderate evidence

Zone 2 cardio

Conversational-pace cardio, 150+ minutes per week, in line with WHO's moderate-intensity guideline.

Read full evidence

Why

Zone 2 is the intensity at which you can still hold a conversation but a song would be a stretch, roughly 60–70% of max heart rate. This exact intensity has not been tested; WHO strongly recommends 150–300 minutes a week of moderate-intensity aerobic activity for adults, and cohort studies link that kind of activity to lower all-cause mortality. Sustained Zone 2 work is proposed to increase mitochondrial density and improve fat oxidation.

Slot in your day

Anytime

How to do it

How

Brisk walk, easy bike, slow jog. 30 minutes × 5 days, or 45–60 min × 3 days. The 'talk test' is the simplest gauge.

Ideal for

Anyone over 30; especially valuable as the foundation before adding higher-intensity work.

Sticking with it

Schedule it like a meeting. The session you 'fit in if there's time' is the session that doesn't happen.

Markers this may influence

Evidence

At a glance

WHO's 2020 physical activity guidelines strongly recommend 150-300 minutes a week of moderate-intensity aerobic activity for adults, on moderate-certainty evidence of lower all-cause and cardiovascular mortality. Kelly 2014 Int J Behav Nutr Phys Act meta-analysis of cohort studies: about 11 MET-hours a week of walking or cycling was associated with 11% and 10% lower all-cause mortality. The specific 'zone 2' intensity was not tested.

GRADE certainty: Moderate — reported by WHO 2020 guidelines (moderate certainty for aerobic activity of 150-300 min/week)

Take to your physician

Worth discussing

  • Whether PSA screening makes sense for you given your age, family history, ethnicity, and personal values about overdiagnosis risk.
  • If PSA is elevated, what the workup path looks like (repeat, mpMRI, potentially biopsy) before assuming the worst.
  • If diagnosed with prostate cancer, whether active surveillance is appropriate for indolent disease (most early-stage cancers detected by screening qualify).

Sources

Cited literature

Last reviewed October 2026

Educational reference. Population-level information for the longevity-curious reader. Healicus does not compute scores, interpret your specific values, or produce personalised recommendations from your clinical data. Discuss your own results and any decisions with your physician.

Keep reading